Natera · 16 hours ago
ABMGG Laboratory Director
San Carlos, CA
Full-time
Onsite
Lead/Staff, Director/Executive
$185K/yr - $231K/yr
5+ years expNatera is a global leader in cell-free DNA testing, focusing on oncology, women’s health, and organ health. They are seeking a Laboratory Director to oversee clinical testing, ensure regulatory compliance, and provide accurate patient test results while managing laboratory personnel and maintaining high standards of performance.
BiotechnologyGeneticsHealth DiagnosticsMedicalWomen's
Responsibilities
Review, approve, and sign-out reports for a variety of clinical molecular/cytogenetic and/or oncologic results, including NIPT, carrier screening, PGD/PGS, products of conception and oncology testing on platforms including SNP array analysis, NGS, and other methodologies
Oversee the review of genetic and CNV variant data: interpret NGS and microarray results in the context of medical literature, online variant databases and other references along with relevant patient demographic data
Provide clinical and technical support for genetic counselors and other laboratory personnel
Set standards for laboratory testing and acceptable levels of analytic performance and ensure these are maintained
Analyze lab data, contribute to or write publications for high-quality scientific journals
Test reports include pertinent information for test interpretation, and availability for consultation concerning test results and the interpretation of those results as they relate to specific patient conditions
Appropriate test method selection, adequate method verification to determine the accuracy and precision of the test, enrollment of the laboratory in a CMS-approved proficiency testing (PT) program for the test performed, PT samples are tested in accordance with the CLIA requirements, PT results are returned within the time frames established by the PT program, PT reports are reviewed by the appropriate staff, corrective action plans are followed when PT results are found to be unacceptable or unsatisfactory, quality assessment and quality control programs are established and maintained, acceptable analytical test performance is established and maintained for each test system, remedial actions are taken and documented when significant deviations from the laboratory’s established performance characteristics are identified, and patient test results are reported only when the system is functioning properly, personnel have been appropriately trained and demonstrate competency prior to testing patient specimens, policies and procedures are established for monitoring personnel competency in all phases (preanalytical, analytical, and postanalytical) of testing to assure the ongoing competency of all individuals who perform testing; remedial training or continuing education needs are identified, and training provided; and an approved procedure manual is available to all personnel
Review and approve assigned work; mentor and develop personnel, including dedicated succession planning and contingency management
This role works with PHI on a regular basis both in paper and electronic form and has an access to various technologies to access PHI (paper and electronic) in order to perform the job
Employee must complete training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training and security training as soon as possible but not later than the first 30 days of hire
Must maintain a current status on Natera training requirements
Employee must pass post offer criminal background check
Qualification
Required
MD/DO and/or PhD in genetics or related field required
ABMGG board-certified in Clinical Cytogenetics and/or Molecular Genetics, ABP board-certified in Molecular Genetic Pathology, or equivalent doctoral-level board required
Current California laboratory director license as a Clinical Genetic Molecular Biologist or Clinical Cytogeneticist required
Current Certificate of Qualification in Genetic Testing from the NYS CLEP required
5 or more years of experience in a CLIA-certified clinical laboratory setting analyzing, interpreting and reporting clinical genetic/genomic data
Knowledge of CAP, CLIA, California, and New York state regulations
Management experience required
Excellent written and oral communication skills
Experience leading a laboratory offering prenatal screening and oncology testing and evaluating, interpreting, and reporting out NGS and microarray data
Familiarity with next-generation sequencing, and/or knowledge of advanced methods of copy number detection
Strong background in human and medical genetics, and oncology with a familiarity of online human genomics
Understanding of statistical measures utilized in genetic testing and screening
Benefits
Annual performance incentive bonus
Long-term equity awards
Comprehensive health benefits (medical, dental, vision)
401(k) with company match
Generous paid time off and company holidays
Additional wellness and work-life benefits
Employee benefits include comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents.
Natera employees and their immediate families receive free testing in addition to fertility care benefits.
Other benefits include pregnancy and baby bonding leave, 401k benefits, commuter benefits and much more.
We also offer a generous employee referral program!
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
5001-10000 employees
H1B Sponsorship
Natera has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (90)
2024 (72)
2023 (37)
2022 (71)
2021 (64)
2020 (40)
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Sofinnova InvestmentsLightspeed Venture PartnersSequoia Capital
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Leadership Team
Steve Chapman
CEO
Jonathan Sheena
Co-Founder, Board Member
Recent News
2026-01-22
Business Wire
2026-01-22
Company data provided by crunchbase